These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11098284)
1. International Symposium on Neuromuscular Disorders state-of-the-art at the edge of the millennium Brussels, December 11th, 1999. Van den Bergh PY Acta Neurol Belg; 2000 Sep; 100(3):141. PubMed ID: 11098284 [No Abstract] [Full Text] [Related]
2. Report on the 3rd Ottawa International Conference on Neuromuscular Biology, Disease and Therapy - September 24-26, 2015, Ottawa, Canada. Chardon JW; Jasmin BJ; Kothary R; Parks RJ J Neuromuscul Dis; 2016 Aug; 3(3):431-442. PubMed ID: 27854234 [No Abstract] [Full Text] [Related]
3. A 2020 centenary perspective on neuromuscular disorders. Goutman SA; Callaghan BC; Feldman E J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):791-792. PubMed ID: 32665324 [No Abstract] [Full Text] [Related]
4. [NeuroMyoGene Institute: a Franco-Canadian partnership promoting research in neuromuscular disorders]. Schaeffer L Med Sci (Paris); 2016 Nov; 32 Hors série n°2():55-56. PubMed ID: 27869078 [No Abstract] [Full Text] [Related]
5. Therapy update in nerve, neuromuscular junction and myopathic disorders. Sadeghian H; Wolfe GI Curr Opin Neurol; 2010 Oct; 23(5):496-501. PubMed ID: 20664347 [TBL] [Abstract][Full Text] [Related]
6. Neuromuscular disease: new insights and avenues for therapy. Scotter EL; Shaw CE Lancet Neurol; 2013 Jan; 12(1):13-5. PubMed ID: 23237893 [No Abstract] [Full Text] [Related]
7. Neuromuscular Gene Therapy: Catching the Wave of Positive Early Studies Is Expected to Crest in Product Approvals. Byrne BJ Mol Ther; 2019 Oct; 27(10):1695-1696. PubMed ID: 31558355 [No Abstract] [Full Text] [Related]
8. New therapies for neuromuscular diseases in 2018. Shah AM; Al-Chalabi A Lancet Neurol; 2019 Jan; 18(1):12-13. PubMed ID: 30563673 [No Abstract] [Full Text] [Related]
9. Opportunities and challenges for the development of antisense treatment in neuromuscular disorders. van Putten M; Aartsma-Rus A Expert Opin Biol Ther; 2011 Aug; 11(8):1025-37. PubMed ID: 21510827 [TBL] [Abstract][Full Text] [Related]
11. Neuromuscular diseases: milestones in development of treatments. Bushby K Lancet Neurol; 2011 Jan; 10(1):11-3. PubMed ID: 21163438 [No Abstract] [Full Text] [Related]
12. Neuromuscular diseases rehabilitation in the era of gene therapy. Trabacca A Neurol Sci; 2020 Jul; 41(7):1971-1972. PubMed ID: 32034556 [No Abstract] [Full Text] [Related]
13. Current concerns in the therapy of neuromuscular disorders. Dubowitz V Neuromuscul Disord; 2011 Jan; 21(1):3. PubMed ID: 21130653 [No Abstract] [Full Text] [Related]
15. [The telethon and the promises not kept by gene therapy]. Nau JY Rev Med Suisse; 2013 Dec; 9(411):2402-3. PubMed ID: 24693592 [No Abstract] [Full Text] [Related]
16. Gene-based therapies of neuromuscular disorders: an update and the pivotal role of patient organizations in their discovery and implementation. Braun S J Gene Med; 2013; 15(11-12):397-413. PubMed ID: 24123726 [TBL] [Abstract][Full Text] [Related]
17. Perspectives on best practices for gene therapy programs. Cheever TR; Berkley D; Braun S; Brown RH; Byrne BJ; Chamberlain JS; Cwik V; Duan D; Federoff HJ; High KA; Kaspar BK; Klinger KW; Larkindale J; Lincecum J; Mavilio F; McDonald CL; McLaughlin J; Weiss McLeod B; Mendell JR; Nuckolls G; Stedman HH; Tagle DA; Vandenberghe LH; Wang H; Wernett PJ; Wilson JM; Porter JD; Gubitz AK Hum Gene Ther; 2015 Mar; 26(3):127-33. PubMed ID: 25654329 [TBL] [Abstract][Full Text] [Related]
18. Cardiac function tests in neuromuscular diseases. Bhakta D; Groh WJ Neurol Clin; 2004 Aug; 22(3):591-617, vi. PubMed ID: 15207877 [TBL] [Abstract][Full Text] [Related]
19. Neuromuscular Disorders in Children and Adolescents. Korinthenberg R Neuropediatrics; 2017 Aug; 48(4):209-210. PubMed ID: 28738441 [No Abstract] [Full Text] [Related]